Advertisements



With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis

With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis.....»»

Category: topSource: seekingalphaJun 13th, 2018

Amgen"s Neulasta Has a New Competitor

Mylan's biosimilar receives FDA approval for commercialization in the USRelated Stocks: AMGN, MYL,.....»»

Category: blogSource: gurufocusJun 17th, 2018

Mylan shares zoom on key approval and $4.5 billion market opportunity

The company scored the first U.S. approval of a biosimilar Neulasta late Monday, a lucrative product that has brought in billions in sales......»»

Category: topSource: marketwatchJun 6th, 2018

Mylan (MYL) Gets FDA Approval for Biosimilar of Neulasta

Mylan (MYL) and partner Biocon get a significant boost with t.....»»

Category: smallbizSource: nytJun 5th, 2018

Mylan shares zoom 7% on key approval and $4.5 billion market opportunity

The company scored the first U.S. approval of a biosimilar Neulasta late Monday, a lucrative product that has brought in billions in sales......»»

Category: topSource: marketwatchJun 5th, 2018

Mylan Wins Big With FDA Approval

Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim)......»»

Category: blogSource: 247wallstJun 5th, 2018

Mylan"s Biosimilar of Neulasta Gets Positive CHMP Opinion

Zacks.....»»

Category: topSource: redinewsSep 24th, 2018

Mylan"s Biosimilar of Neulasta Gets Positive CHMP Opinion

Mylan (MYL) gets a positive CHMP opinion for Fulphila, a proposed biosimilar of Amgen's Neulasta. Mylan N......»»

Category: dealsSource: nytSep 24th, 2018

Mylan, Lupin Collaborate for the Proposed Biosimilar Enbrel

Mylan (MYL) enters a partnership with Lupin Limited to commercialize a biosimilar of blockbuster drug Enbrel on approval. Mylan N.V. MYL and India-based Lupin Limited have ent.....»»

Category: dealsSource: nytJun 28th, 2018

Mylan to have only a "minor" delay to generic Advair approval, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Neulasta biosimilar could "reignite" Mylan momentum, says Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018

Jefferies thesis on Amgen unchanged after Mylan biosimilar approval

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018

Benzinga"s Daily Biotech Pulse: Mylan"s Neulasta Biosimilar Approved, Portola"s CEO To Retire, Regenxbio To Join S&P SmallCap Index

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 4) read more.....»»

Category: blogSource: benzingaJun 5th, 2018

Amgen falls after Neulasta biosimilar approved by FDA, Mylan spikes higher

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Mylan And Coherus: How To Play The Upcoming Neulasta Biosimilar Race

Mylan And Coherus: How To Play The Upcoming Neulasta Biosimilar Race.....»»

Category: topSource: seekingalphaJun 3rd, 2018

Biocon 483 letter won"t delay approval of Mylan"s Neulasta, says Bernstein

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2018

Autodesk (ADSK) in Focus: Stock Moves 5.6% Higher

Aut.....»»

Category: dealsSource: nytOct 15th, 2018

Merck returning Lantus biosimilar rights negative for Mylan, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 12th, 2018

U.S.-Mexico trade deal text to be released as focus remains on Canada

The text of the Trump administration's trade agreement with Mexico is due to be released on Friday, launching a contentious approval process as pressure mounts on Canada to sign a revamping of the trilateral NAFTA pact......»»

Category: topSource: reutersSep 28th, 2018

Novartis Gets Positive CHMP Opinion for Drugs, Biosimilar

Novartis (NVS) gets positive CHMP opinion for a label expansion of Gilenya, gene therapy, and a biosimilar of Neulasta. Novartis AG NVS announced that the Committee for Medi.....»»

Category: personnelSource: nytSep 24th, 2018

Asia Markets: Asian markets mostly rise, as Nikkei logs 5th straight gain

Asian stock markets mostly rose Thursday as investors set aside trade concerns, for now, to focus on tech-share and financial-stock moves......»»

Category: topSource: marketwatchSep 20th, 2018